-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下:在PNR公佈第一季財報後,我們將12個月目標價從130美元下調至115美元,該估值基於我們2027年每股收益預期5.91美元(下調0.01美元;2026年每股收益預期與此前預測一致),市盈率為19.5倍,略高於公司歷史平均市盈率。我們認為,鑑於PNR在水技術領域的多元化投資組合策略能夠降低獲利波動性,這項溢價是合理的。雖然第一季業績符合我們的預期,但有機銷售成長令人擔憂,因為管理層警告稱,泳池業務即將進行通路庫存調整。鑑於該業務板塊盈利能力領先,任何銷售額或產品組合的下滑都可能對整體利潤率造成壓力。儘管面臨泳池業務的不利因素,我們預計PNR的利潤率仍將保持上升趨勢,因為流量和水處理解決方案業務將透過有針對性的生產力提升計畫和定價策略來提高利潤率。我們認為第一季的不利因素已反映在股價中,因此重申我們的「強烈買入」評級。
Related Articles
BNP Paribas Adjusts Price Target on Ingersoll Rand to $82 From $94
Ingersoll Rand (IR) has an average rating of overweight and mean price target of $96.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $77.89, Change: $+0.43, Percent Change: +0.56%
Mizuho Adjusts Price Target on Humana to $290 From $258
Humana (HUM) has an average rating of hold and mean price target of $228.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $242.12, Change: $-1.00, Percent Change: -0.41%
Jefferies Adjusts Price Target on Humana to $290 From $235
Humana (HUM) has an average rating of hold and mean price target of $228.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $242.12, Change: $-1.00, Percent Change: -0.41%